Literature DB >> 24379224

Acute lower respiratory infection among Bacille Calmette-Guérin (BCG)-vaccinated children.

Maria-Graciela Hollm-Delgado1, Elizabeth A Stuart, Robert E Black.   

Abstract

OBJECTIVE: To determine whether Bacille Calmette-Guerin (BCG) vaccination is linked to the risk of acute lower respiratory infection (ALRI) among children <5 years of age.
METHODS: Data from Macro International Demographic and Health Surveys and United Nations Children's Fund Multiple Indicator Cluster Surveys were used to identify a primary cohort of 58,021 children in 19 countries (2005-2010) and a secondary cohort of 93,301 children in 18 countries (2000-2007). Information was collected by trained interviewers during home visits using standardized questionnaires, review of vaccination health cards, and measurement of health indicators.
RESULTS: BCG vaccination was associated with a 17% to 37% risk reduction for suspected ALRI in both cohorts. The only vaccine or vitamin supplement to modify the effect of BCG was diphtheria-tetanus-pertussis (DTP; P < .001). The order in which the vaccines were first received was central to this phenomena (BCG before DTP, adjusted/propensity score-weighted relative risk [apRR]: 0.79, 95% confidence interval [CI]: 0.70-0.89; BCG with DTP, apRR: 0.82, 95% CI: 0.71-0.94; and BCG after DTP, apRR: 1.00, 95% CI: 0.87-1.13) but not number of DTP doses received. Other modifiers included vaccine strain used in immunization programs, chlorinating drinking water, using wood-burning fuel cook stoves, and owning livestock.
CONCLUSIONS: Children vaccinated with BCG had a significantly lower risk of suspected ALRI. Clarification is needed as to whether this is due to reductions in the underlying risk of tuberculosis or ALRI per se.

Entities:  

Keywords:  Bacille Calmette-Guerin (BCG) vaccine; childhood immunization; developing countries; diphtheria-tetanus-pertussis (DTP) vaccine; respiratory tract infection

Mesh:

Substances:

Year:  2013        PMID: 24379224     DOI: 10.1542/peds.2013-2218

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  36 in total

1.  SARS-CoV-2 Rates in BCG-Vaccinated and Unvaccinated Young Adults.

Authors:  Uri Hamiel; Eran Kozer; Ilan Youngster
Journal:  JAMA       Date:  2020-06-09       Impact factor: 56.272

2.  Live attenuated pertussis vaccine for prevention and treatment of allergic airway inflammation in mice.

Authors:  Thomas Belcher; Saliha Ait-Yahia; Luis Solans; Anne-Sophie Debrie; Stephane Cauchi; Anne Tsicopoulos; Camille Locht
Journal:  NPJ Vaccines       Date:  2022-06-23       Impact factor: 9.399

3.  Antituberculosis BCG vaccination: more reasons for varying innate and adaptive immune responses.

Authors:  S Prentice; H M Dockrell
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

Review 4.  BCG: a vaccine with multiple faces.

Authors:  Marco Antonio Yamazaki-Nakashimada; Alberto Unzueta; Luisa Berenise Gámez-González; Napoleón González-Saldaña; Ricardo U Sorensen
Journal:  Hum Vaccin Immunother       Date:  2020-01-29       Impact factor: 3.452

5.  BCG-induced non-specific effects on heterologous infectious disease in Ugandan neonates: an investigator-blind randomised controlled trial.

Authors:  Sarah Prentice; Beatrice Nassanga; Emily L Webb; Florence Akello; Fred Kiwudhu; Hellen Akurut; Alison M Elliott; Rob J W Arts; Mihai G Netea; Hazel M Dockrell; Stephen Cose
Journal:  Lancet Infect Dis       Date:  2021-02-17       Impact factor: 71.421

Review 6.  Linking Susceptibility to Infectious Diseases to Immune System Abnormalities among HIV-Exposed Uninfected Infants.

Authors:  Candice Ruck; Brian A Reikie; Arnaud Marchant; Tobias R Kollmann; Fatima Kakkar
Journal:  Front Immunol       Date:  2016-08-19       Impact factor: 7.561

7.  BCG therapy is associated with long-term, durable induction of Treg signature genes by epigenetic modulation.

Authors:  Ryan C Keefe; Hiroyuki Takahashi; Lisa Tran; Kacie Nelson; Nathan Ng; Willem M Kühtreiber; Denise L Faustman
Journal:  Sci Rep       Date:  2021-07-22       Impact factor: 4.379

Review 8.  An update review of globally reported SARS-CoV-2 vaccines in preclinical and clinical stages.

Authors:  Hamid Motamedi; Marzie Mahdizade Ari; Shirin Dashtbin; Matin Fathollahi; Hadi Hossainpour; Amirhoushang Alvandi; Jale Moradi; Ramin Abiri
Journal:  Int Immunopharmacol       Date:  2021-05-06       Impact factor: 5.714

Review 9.  BCG turns 100: its nontraditional uses against viruses, cancer, and immunologic diseases.

Authors:  Alok K Singh; Mihai G Netea; William R Bishai
Journal:  J Clin Invest       Date:  2021-06-01       Impact factor: 19.456

10.  Non-specific Effects of Vaccines and Stunting: Timing May Be Essential.

Authors:  Mike L T Berendsen; Jeroen Smits; Mihai G Netea; André van der Ven
Journal:  EBioMedicine       Date:  2016-05-12       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.